SCHEMBL7325851

SCHEMBL7325851

O=C(O)CNC(=O)[C@@H](CC(=O)NO)Cc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MME P08473 5/20 1.00
ALDH1A1 P00352 2/20 0.67
ACE P12821 2/20 0.67
ECE1 P42892 2/20 0.67
HPGD P15428 1/20 0.67
MAPK1 P28482 1/20 0.67
HSD17B10 Q99714 1/20 0.67
MEN1 O00255 1/20 0.67
MAPT P10636 1/20 0.67
BLM P54132 1/20 0.67
NPEPPS P55786 1/20 0.67
KMT2A Q03164 1/20 0.67
LTA4H P09960 1/20 0.63
ANPEP P15144 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7325845 1.00 MME (1.00) MMEALDH1A1ACEECE1HPGD
SCHEMBL7325857 1.00 MME (1.00) MMEALDH1A1ACEECE1HPGD
SCHEMBL10447979 0.86 MME (0.81) MMEALDH1A1ACEECE1HPGD
SCHEMBL10692379 0.82 MME (0.70) MMEALDH1A1ACEECE1HPGD
SCHEMBL10691553 0.82 MME (0.70) MMEALDH1A1ACEECE1HPGD
SCHEMBL825762 0.81 MME (0.74) MMEALDH1A1ACEECE1HPGD
SCHEMBL7103054 0.81 MME (0.74) MMEALDH1A1ACEECE1HPGD
SCHEMBL9622302 0.80 MME (0.72) MMEALDH1A1ACEECE1HPGD
Thiorphan SCHEMBL401174 0.80 MME (1.00) MMEALDH1A1ACEECE1HPGD
(R)-Thiorphan SCHEMBL7312756 0.80 MME (1.00) MMEALDH1A1ACEECE1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0566157-A1 Neutral metalloendopeptidase inhibitors in the treatment of hypertension SCHERING CORPORATION (US) 1993-10-20 EP disclosed
US-4749688-A Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension SCHERING CORPORATION (US) 1988-06-07 US disclosed
EP-0254032-A2 Neutral metalloendopeptidase inhibitors in the treatment of hypertension SCHERING CORPORATION (US) 1988-01-27 EP disclosed